Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-12 06:06 am Sale | 13G | LendingClub Corp LC | Rubric Capital Management LP | 0 0% | -5,826,128 (Position Closed) | View |
| 2024-02-12 06:06 am Purchase | 13G | Orthofix Medical Inc. OFIX | Rubric Capital Management LP | 3,665,000 9.97% | 3,665,000 (New Position) | View |
| 2024-02-12 06:06 am Sale | 13G | Playa Hotels & Resorts N.V. PLYA | Rubric Capital Management LP | 4,431,161 3.2% | -7,445,567 (-62.69%) | View |
| 2024-02-12 06:06 am Purchase | 13G | STRATASYS LTD. SSYS | Rubric Capital Management LP | 4,250,000 6.15% | 4,250,000 (New Position) | View |
| 2024-02-12 06:06 am Unchanged | 13G | Trevi Therapeutics Inc. TRVI | Rubric Capital Management LP | 5,684,420 8.9% | 0 (Unchanged) | View |
| 2024-02-12 06:06 am Sale | 13G | TELESAT CORP & SHS I TSAT | Rubric Capital Management LP | 959,764 7.12% | -450,236 (-31.93%) | View |
| 2024-01-23 4:00 pm Sale | 13D | XPERI INC XPER | Rubric Capital Management LP | 3,301,219 7.6% | -542,525 (-14.11%) | View |
| 2023-11-20 08:45 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 99,704,885 14.22% | 2,378,330 (+2.44%) | View |
| 2023-11-17 09:28 am Purchase | 13D | THERAPEUTICSMD INC TXMD | Rubric Capital Management LP | 2,946,908 25.73% | 877,192 (+42.38%) | View |
| 2023-11-15 07:56 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 97,326,555 13.88% | 7,200 (+0.01%) | View |
| 2023-11-13 07:31 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 97,319,355 13.88% | 1,758,195 (+1.84%) | View |
| 2023-11-08 07:06 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 95,561,160 13.63% | 2,188,575 (+2.34%) | View |
| 2023-11-06 07:30 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 93,372,585 13.32% | 1,081,380 (+1.17%) | View |
| 2023-11-02 07:30 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 92,291,205 13.25% | 92,130 (+0.10%) | View |
| 2023-10-30 6:02 pm Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 92,199,075 13.15% | 2,168,475 (+2.41%) | View |
| 2023-07-25 4:13 pm Purchase | 13D | HERON THERAPEUTICS INC HRTX | Rubric Capital Management LP | 26,713,503 19% | 14,963,503 (+127.35%) | View |
| 2023-06-30 08:29 am Purchase | 13D | THERAPEUTICSMD INC TXMD | Rubric Capital Management LP | 2,069,716 19.57% | 347,763 (+20.20%) | View |
| 2023-06-16 08:00 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 90,030,600 14.41% | 6,250,000 (+7.46%) | View |
| 2023-05-02 5:07 pm Sale | 13G | CHIMERIX INC CMRX | Rubric Capital Management LP | 4,779,020 5.39% | -2,720,980 (-36.28%) | View |
| 2023-02-22 4:24 pm Unchanged | 13D | HERON THERAPEUTICS INC HRTX | Rubric Capital Management LP | 11,750,000 9.9% | 0 (Unchanged) | View |